Insider: Poulton Jeffrey V. EVP, Chief Financial Officer - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 64,050 | 0 | 64,050 |
| Value | $20,422,342.50 | $0.00 | $20,422,342.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 109 | Direct | COM | $320.01 | $34,881.09 | 64,050 |
| 03/04/2026 | DDS | 114 | Direct | COM | $319.03 | $36,369.42 | 64,159 |
| 03/04/2026 | DDS | 223 | Direct | COM | $325.67 | $72,624.41 | 61,805 |
| 03/04/2026 | DDS | 309 | Direct | COM | $321.82 | $99,442.38 | 63,511 |
| 03/04/2026 | DDS | 230 | Direct | COM | $320.81 | $73,786.30 | 63,820 |
| 03/04/2026 | DDS | 818 | Direct | COM | $323.84 | $264,901.12 | 62,319 |
| 03/04/2026 | DDS | 291 | Direct | COM | $324.88 | $94,540.08 | 62,028 |
| 03/04/2026 | DDS | 374 | Direct | COM | $323.01 | $120,805.74 | 63,137 |
| 03/02/2026 | DDS | 356 | Direct | COM | $325.63 | $115,924.28 | 65,934 |
| 03/02/2026 | DDS | 124 | Direct | COM | $324.65 | $40,256.60 | 66,290 |
| 03/02/2026 | DDS | 65 | Direct | COM | $323.62 | $21,035.30 | 66,414 |
| 03/02/2026 | DDS | 454 | Direct | COM | $327.67 | $148,762.18 | 64,939 |
| 03/02/2026 | DDS | 541 | Direct | COM | $326.81 | $176,804.21 | 65,393 |
| 03/02/2026 | DDS | 129 | Direct | COM | $331.93 | $42,818.97 | 64,326 |
| 03/02/2026 | DDS | 112 | Direct | COM | $330.85 | $37,055.20 | 64,455 |
| 03/02/2026 | DDS | 234 | Direct | COM | $329.71 | $77,152.14 | 64,567 |
| 03/02/2026 | DDS | 138 | Direct | COM | $328.71 | $45,361.98 | 64,801 |
| 03/02/2026 | DDS | 53 | Direct | COM | $332.64 | $17,629.92 | 64,273 |
| 02/13/2026 | DDS | 2,242 | Direct | COM | $310.08 | $695,201.15 | 59,802 |
| 01/12/2026 | DDS | 156 | Direct | COM | $359.14 | $56,025.84 | 59,461 |
| 01/12/2026 | DDS | 284 | Direct | COM | $360.22 | $102,302.48 | 59,177 |
| 01/12/2026 | DDS | 181 | Direct | COM | $361.45 | $65,422.45 | 58,996 |
| 01/12/2026 | DDS | 87 | Direct | COM | $363.55 | $31,628.85 | 58,774 |
| 01/12/2026 | DDS | 226 | Direct | COM | $358.18 | $80,948.68 | 59,617 |
| 01/12/2026 | DDS | 72 | Direct | COM | $353.95 | $25,484.40 | 60,173 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research